MarketInOut Stock Screener Log In | Sign Up

Hangzhou Diagens Biotechnology Co Ltd

HKSE • Healthcare • Medical Devices • Quote as of 10/30/2026
Hangzhou Diagens Biotechnology Co Ltd stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeHKSE
Market Capitalization16,887 mln
Float16.63 mln
Earnings Date11/07/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2
Caution advised

Relative Strength

3 / 100
Severely lagging

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-58%
Severely loss-making

ROE

-18.12
Negative

Business Description

Founded in 2016 and based in Hangzhou, China, Diagens Biotechnology develops tools and software that help medical laboratories analyze chromosomes and cells more efficiently. The company's core offerings include AI-powered imaging software, automated cell scanning and harvesting equipment, and cloud-based platforms that support genetic testing and cancer diagnostics. It also provides reagents, consumables, and consulting services to support laboratory workflows from sample preparation through to final analysis.

Key Fundamentals

EPS-1.50
ROE-18.12
ROIC-21.23
ROA-13.93
EBITDA, mln-31.20
EV / EBITDA-539
EV / EBIT-504
Revenue, mln57.93
EV / Revenue290

Quote Details

Last 158.00
Change -22.1 (-12.27%)
Open 178.10
Volume 57,000
Turnover 9,006,000
Average Volume 104,061

Financial Ratios

Pre-Tax Profit Margin-58
Current Ratio3.01
Price / Book83.33
Price / Tangible Book84.07
Debt / Equity0.04
Price / Sales265

Financial Strength

Altman Z-Score182
Piotroski F-Score 5 / 9
Beneish M-Score-2

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -22.7% 1 / 100   
1 Month -47.89% 1 / 100   
2 Months -41.26% 7 / 100   
6 Months -41.7% 20 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog